4th Microbiome Movement – Drug Development Summit Europe 2020

  • February 4, 2020 - February 6, 2020
  • London, UK

Join us:

Biomica is delighted to participate at 4th Microbiome Movement – Drug Development Summit Europe 2020.

Dr. Elran Haber, Biomica’s Chief Executive Officer, will provide an overview of the Company’s work developing live bio-therapeutics using PRISM, a high-resolution microbiome analysis platform and a detailed functional genomic analysis; and participate in a panel discussion on current innovation & Future Integration of Microbiome-Based Approaches into Routine Oncology Practice.

Dr. Haber will be available to participate in one-on-one meetings.

More Details and Registration: https://microbiome-europe.com/

Back to all News

Highlighted News About Biomica

ASCO 2024 logo
Apr 16, 2024

American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

We’re pleased to announce that Dr. Shiri Meshner, our VP of Research and Development, will be participating in the Pharmabiotic Conference 2024. She’ll be presenting alongside Claire Derlot, Chief Business Officer of Biose Industrie, on the topic “Biomica & Biose Industrie: The clinical journey of a multi-strain LBP”. Additionally, Dr. Meshner will contribute to a panel discussion focusing on Clinical Design & Methodology.